A Case-Only Genome-Wide Interaction Study of Smoking and Bladder Cancer Risk: Results from the COBLAnCE Cohort.

bladder cancer case-only design genome-wide association study smoking

Journal

Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829

Informations de publication

Date de publication:
23 Aug 2023
Historique:
received: 06 07 2023
revised: 02 08 2023
accepted: 07 08 2023
medline: 9 9 2023
pubmed: 9 9 2023
entrez: 9 9 2023
Statut: epublish

Résumé

Bladder cancer (BC) is the 6th most common cancer worldwide, with tobacco smoking considered as its main risk factor. Accumulating evidence has found associations between genetic variants and the risk of BC. Candidate gene-environment interaction studies have suggested interactions between cigarette smoking and

Identifiants

pubmed: 37686494
pii: cancers15174218
doi: 10.3390/cancers15174218
pmc: PMC10487226
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : Agence Nationale de la Recherche
ID : Programme Investissements d'Avenir Cohortes ANR-10-COHO-0007
Organisme : Inserm
ID : Soutien aux cohortes pour la Recherche sur le Cancer, AAP 2013
Organisme : Ligue Nationale Contre le Cancer
ID : EP 2011
Organisme : French National Cancer Institute
ID : Research programme and interventions to reduce and fight against tobacco consumption 2019-1-TABAC

Références

Arch Gen Psychiatry. 2008 Jun;65(6):683-93
pubmed: 18519826
G3 (Bethesda). 2011 Nov;1(6):457-70
pubmed: 22384356
Mol Psychiatry. 2022 Nov;27(11):4464-4473
pubmed: 35948661
Nat Genet. 2010 Nov;42(11):978-84
pubmed: 20972438
BJU Int. 2012 Jan;109(1):70-6
pubmed: 21851540
Eur Neuropsychopharmacol. 2020 Jan;30:44-55
pubmed: 29174947
BMJ Open. 2019 Oct 16;9(10):e030396
pubmed: 31619424
Lancet. 2005 Aug 20-26;366(9486):649-59
pubmed: 16112301
Cancer Causes Control. 2019 Feb;30(2):187-193
pubmed: 30656539
Am J Epidemiol. 2009 Jan 15;169(2):219-26
pubmed: 19022827
Eur Urol. 2011 Oct;60(4):713-20
pubmed: 21794974
BJU Int. 2010 Mar;105(6):784-8
pubmed: 19751260
Am J Hum Genet. 2009 Mar;84(3):367-79
pubmed: 19268276
Cancer Epidemiol Biomarkers Prev. 2006 Jul;15(7):1348-54
pubmed: 16835335
J Urol. 2012 Mar;187(3):856-61
pubmed: 22248521
Neuropsychopharmacology. 2010 Feb;35(3):702-19
pubmed: 19890259
Hum Mol Genet. 2014 Mar 1;23(5):1387-98
pubmed: 24163127
Urology. 2005 Aug;66(2):305-10
pubmed: 16098360
Eur Urol. 2010 Feb;57(2):283-92
pubmed: 19692168
PLoS One. 2013 Jun 18;8(6):e67252
pubmed: 23825647
Int J Cancer. 2018 May 1;142(9):1797-1804
pubmed: 29235103
Gigascience. 2015 Feb 25;4:7
pubmed: 25722852
Med Sci (Basel). 2020 Mar 13;8(1):
pubmed: 32183076
Bladder Cancer. 2018 Apr 26;4(2):215-226
pubmed: 29732392
CA Cancer J Clin. 2021 May;71(3):209-249
pubmed: 33538338
Eur Urol. 2023 Jul;84(1):127-137
pubmed: 37210288
PLoS Genet. 2009 Jun;5(6):e1000529
pubmed: 19543373
IARC Monogr Eval Carcinog Risks Hum. 2004;83:1-1438
pubmed: 15285078
Nucleic Acids Res. 2010 Sep;38(16):e164
pubmed: 20601685
Cancer Prev Res (Phila). 2017 Dec;10(12):704-709
pubmed: 28972007
Mutat Res. 2002 Sep 30;506-507:21-8
pubmed: 12351141
Int J Epidemiol. 1984 Sep;13(3):356-65
pubmed: 6386716
JAMA. 2011 Aug 17;306(7):737-45
pubmed: 21846855
Mutat Res. 2002 Sep 30;506-507:65-77
pubmed: 12351146
Nat Genet. 2010 May;42(5):415-9
pubmed: 20348956
Eur Urol. 2013 Feb;63(2):234-41
pubmed: 22877502
Nat Commun. 2014 Jun 13;5:3934
pubmed: 25653097
Stat Med. 1994 Jan 30;13(2):153-62
pubmed: 8122051
Nat Genet. 2008 Nov;40(11):1307-12
pubmed: 18794855
Respir Res. 2018 Mar 22;19(1):46
pubmed: 29566699
J Toxicol Sci. 2020;45(3):177-186
pubmed: 32147640
Nature. 2015 Oct 1;526(7571):68-74
pubmed: 26432245
Nat Genet. 2010 May;42(5):448-53
pubmed: 20418888
Int J Epidemiol. 2007 Feb;36(1):236-41
pubmed: 17510079
Sci Total Environ. 2009 Apr 1;407(8):2593-602
pubmed: 19187950
Cancer Res. 2013 Apr 1;73(7):2211-20
pubmed: 23536561
Ann Oncol. 2020 Feb;31(2):274-282
pubmed: 31959344
Am J Epidemiol. 2002 Mar 1;155(5):478-84
pubmed: 11867360
Mol Biol (Mosk). 2017 Jul-Aug;51(4):603-614
pubmed: 28900078
Transl Psychiatry. 2021 Aug 12;11(1):424
pubmed: 34385417
Nat Genet. 2019 Feb;51(2):237-244
pubmed: 30643251
Ann N Y Acad Sci. 2015 Sep;1349:83-95
pubmed: 25988664
Carcinogenesis. 2014 Aug;35(8):1737-44
pubmed: 24662972

Auteurs

Maryam Karimi (M)

Oncostat U1018 Inserm, Équipe Labellisée Ligue Contre le Cancer, Université Paris-Saclay, 94805 Villejuif, France.
Bureau de Biostatistique et d'Épidémiologie, Gustave Roussy, Université Paris-Saclay, 94805 Villejuif, France.

Sebastian Mendez-Pineda (S)

Oncostat U1018 Inserm, Équipe Labellisée Ligue Contre le Cancer, Université Paris-Saclay, 94805 Villejuif, France.

Hélène Blanché (H)

CEPH-Biobank, Fondation Jean Dausset-CEPH, 75010 Paris, France.

Anne Boland (A)

Centre National de Recherche en Génomique Humaine (CNRGH), CEA, Université Paris-Saclay, 91057 Evry, France.

Céline Besse (C)

Centre National de Recherche en Génomique Humaine (CNRGH), CEA, Université Paris-Saclay, 91057 Evry, France.

Jean-François Deleuze (JF)

CEPH-Biobank, Fondation Jean Dausset-CEPH, 75010 Paris, France.
Centre National de Recherche en Génomique Humaine (CNRGH), CEA, Université Paris-Saclay, 91057 Evry, France.

Xiang-Yu Meng (XY)

CNRS UMR144, Curie Institute, 75005 Paris, France.

Nanor Sirab (N)

Curie Institute, CNRS, UMR144, Molecular Oncology Team, PSL Research University, 75005 Paris, France.

Karine Groussard (K)

Oncostat U1018 Inserm, Équipe Labellisée Ligue Contre le Cancer, Université Paris-Saclay, 94805 Villejuif, France.

Thierry Lebret (T)

Urology, Foch Hospital, 92150 Suresnes, France.

Julia Bonastre (J)

Oncostat U1018 Inserm, Équipe Labellisée Ligue Contre le Cancer, Université Paris-Saclay, 94805 Villejuif, France.
Bureau de Biostatistique et d'Épidémiologie, Gustave Roussy, Université Paris-Saclay, 94805 Villejuif, France.

Yves Allory (Y)

CNRS UMR144, Curie Institute, 75005 Paris, France.
UVSQ, Curie Institute, Department of Pathology, Université Paris-Saclay, 92210 Saint-Cloud, France.

François Radvanyi (F)

CNRS UMR144, Curie Institute, 75005 Paris, France.

Simone Benhamou (S)

Oncostat U1018 Inserm, Équipe Labellisée Ligue Contre le Cancer, Université Paris-Saclay, 94805 Villejuif, France.

Stefan Michiels (S)

Oncostat U1018 Inserm, Équipe Labellisée Ligue Contre le Cancer, Université Paris-Saclay, 94805 Villejuif, France.
Bureau de Biostatistique et d'Épidémiologie, Gustave Roussy, Université Paris-Saclay, 94805 Villejuif, France.

Classifications MeSH